1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

First Light Asset Management, LLC Buys Tandem Diabetes Care Inc, Mylan NV, Teva Pharmaceutical Industries, Sells Agios Pharmaceuticals Inc, Amarin Corp PLC, Bristol-Myers Squibb Company

Bloomington, MN, based Investment company First Light Asset Management, LLC (Current Portfolio) buys Tandem Diabetes Care Inc, Mylan NV, Teva Pharmaceutical Industries, Portola Pharmaceuticals Inc, bluebird bio Inc, sells Agios Pharmaceuticals Inc, Amarin Corp PLC, Bristol-Myers Squibb Company, Takeda Pharmaceutical Co, Ionis Pharmaceuticals Inc during the 3-months ended 2019Q4, according to the most recent filings of the investment company, First Light Asset Management, LLC. As of 2019Q4, First Light Asset Management, LLC owns 68 stocks with a total value of $782 million. These are the details of the buys and sells.

For the details of First Light Asset Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/first+light+asset+management%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of First Light Asset Management, LLC
  1. Model N Inc (MODN) - 1,960,725 shares, 8.79% of the total portfolio. Shares reduced by 0.47%
  2. Oxford Immunotec Global PLC (OXFD) - 4,081,055 shares, 8.66% of the total portfolio. Shares added by 9.73%
  3. Repro-Med Systems Inc (KRMD) - 7,218,014 shares, 6.03% of the total portfolio. Shares added by 0.53%
  4. NeoGenomics Inc (NEO) - 1,336,949 shares, 5.00% of the total portfolio. Shares added by 1.30%
  5. MyoKardia Inc (MYOK) - 531,884 shares, 4.96% of the total portfolio. Shares reduced by 0.39%
New Purchase: Global Blood Therapeutics Inc (GBT)

First Light Asset Management, LLC initiated holding in Global Blood Therapeutics Inc. The purchase prices were between $45.7 and $81.86, with an estimated average price of $59.89. The stock is now traded at around $70.73. The impact to a portfolio due to this purchase was 0.14%. The holding were 14,000 shares as of .

New Purchase: Bio-Rad Laboratories Inc (BIO)

First Light Asset Management, LLC initiated holding in Bio-Rad Laboratories Inc. The purchase prices were between $319.73 and $374.2, with an estimated average price of $353.5. The stock is now traded at around $403.63. The impact to a portfolio due to this purchase was 0.03%. The holding were 548 shares as of .

New Purchase: UnitedHealth Group Inc (UNH)

First Light Asset Management, LLC initiated holding in UnitedHealth Group Inc. The purchase prices were between $215.36 and $295.97, with an estimated average price of $263.11. The stock is now traded at around $298.78. The impact to a portfolio due to this purchase was 0.03%. The holding were 692 shares as of .

New Purchase: Agilent Technologies Inc (A)

First Light Asset Management, LLC initiated holding in Agilent Technologies Inc. The purchase prices were between $72.49 and $85.45, with an estimated average price of $78.92. The stock is now traded at around $85.82. The impact to a portfolio due to this purchase was 0.03%. The holding were 2,548 shares as of .

New Purchase: Anthem Inc (ANTM)

First Light Asset Management, LLC initiated holding in Anthem Inc. The purchase prices were between $234.82 and $306.42, with an estimated average price of $276.42. The stock is now traded at around $297.82. The impact to a portfolio due to this purchase was 0.03%. The holding were 795 shares as of .

Added: Tandem Diabetes Care Inc (TNDM)

First Light Asset Management, LLC added to a holding in Tandem Diabetes Care Inc by 97.01%. The purchase prices were between $53.13 and $71.19, with an estimated average price of $61.87. The stock is now traded at around $86.03. The impact to a portfolio due to this purchase was 1.01%. The holding were 268,574 shares as of .

Added: Mylan NV (MYL)

First Light Asset Management, LLC added to a holding in Mylan NV by 182.96%. The purchase prices were between $17.01 and $20.1, with an estimated average price of $18.63. The stock is now traded at around $21.90. The impact to a portfolio due to this purchase was 0.89%. The holding were 532,783 shares as of .

Added: Teva Pharmaceutical Industries Ltd (TEVA)

First Light Asset Management, LLC added to a holding in Teva Pharmaceutical Industries Ltd by 70.87%. The purchase prices were between $6.53 and $10.72, with an estimated average price of $9. The stock is now traded at around $12.22. The impact to a portfolio due to this purchase was 0.86%. The holding were 1,656,171 shares as of .

Added: Portola Pharmaceuticals Inc (PTLA)

First Light Asset Management, LLC added to a holding in Portola Pharmaceuticals Inc by 32.05%. The purchase prices were between $23.84 and $30.62, with an estimated average price of $27.6. The stock is now traded at around $13.65. The impact to a portfolio due to this purchase was 0.75%. The holding were 1,008,957 shares as of .

Added: bluebird bio Inc (BLUE)

First Light Asset Management, LLC added to a holding in bluebird bio Inc by 246.52%. The purchase prices were between $72.5 and $95.22, with an estimated average price of $83.99. The stock is now traded at around $89.31. The impact to a portfolio due to this purchase was 0.51%. The holding were 64,587 shares as of .

Sold Out: Agios Pharmaceuticals Inc (AGIO)

First Light Asset Management, LLC sold out a holding in Agios Pharmaceuticals Inc. The sale prices were between $30.08 and $50.59, with an estimated average price of $38.07.

Sold Out: Takeda Pharmaceutical Co Ltd (TAK)

First Light Asset Management, LLC sold out a holding in Takeda Pharmaceutical Co Ltd. The sale prices were between $16.88 and $20.83, with an estimated average price of $19.19.

Sold Out: Aduro Biotech Inc (ADRO)

First Light Asset Management, LLC sold out a holding in Aduro Biotech Inc. The sale prices were between $0.94 and $1.22, with an estimated average price of $1.09.

Sold Out: Homology Medicines Inc (FIXX)

First Light Asset Management, LLC sold out a holding in Homology Medicines Inc. The sale prices were between $11.42 and $22.19, with an estimated average price of $15.98.

Sold Out: Alkermes PLC (ALKS)

First Light Asset Management, LLC sold out a holding in Alkermes PLC. The sale prices were between $17.29 and $21.74, with an estimated average price of $19.94.

Sold Out: 10x Genomics Inc (TXG)

First Light Asset Management, LLC sold out a holding in 10x Genomics Inc. The sale prices were between $46.07 and $79.54, with an estimated average price of $60.66.



Here is the complete portfolio of First Light Asset Management, LLC. Also check out:

1. First Light Asset Management, LLC's Undervalued Stocks
2. First Light Asset Management, LLC's Top Growth Companies, and
3. First Light Asset Management, LLC's High Yield stocks
4. Stocks that First Light Asset Management, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)